Literature DB >> 1268610

Editorial: Alternatives to levodopa.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1268610      PMCID: PMC1639739     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  10 in total

1.  Protein intake and treatment of Parkinson's disease with levodopa.

Authors:  I Mena; G C Cotzias
Journal:  N Engl J Med       Date:  1975-01-23       Impact factor: 91.245

2.  Patterns of clinical response and plasma dopa levels in Parkinson's disease.

Authors:  E S Tolosa; W E Martin; H P Cohen; R L Jacobson
Journal:  Neurology       Date:  1975-02       Impact factor: 9.910

3.  Excitation-mediating and inhibition-mediating dopamine-receptors: a new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data.

Authors:  A R Cools; J M Van Rossum
Journal:  Psychopharmacologia       Date:  1976-02-02

4.  Studies on the antiparkinsonism efficacy of lergotrile.

Authors:  A Lieberman; T Miyamoto; A F Battista; M Goldstein
Journal:  Neurology       Date:  1975-05       Impact factor: 9.910

5.  Plasma dopa concentrations and the "on-off" effect after chronic treatment of Parkinson's disease.

Authors:  R D Sweet; F H McDowell
Journal:  Neurology       Date:  1974-10       Impact factor: 9.910

6.  Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum.

Authors:  S Lal; C E De la Vega; T L Sourkes; H G Friesen
Journal:  J Clin Endocrinol Metab       Date:  1973-11       Impact factor: 5.958

7.  The inhibition of prolactin secretion in man by CB-154 (2-Br-alpha-ergocryptine).

Authors:  E Del Pozo; R B Del Re; L Varga; H Friesen
Journal:  J Clin Endocrinol Metab       Date:  1972-11       Impact factor: 5.958

8.  Treatment of Parkinson's disease with aporphines. Possible role of growth hormone.

Authors:  G C Cotzias; P S Papavasiliou; E S Tolosa; J S Mendez; M Bell-Midura
Journal:  N Engl J Med       Date:  1976-03-11       Impact factor: 91.245

9.  On-off response. Clinical and biochemical correlations during oral and intravenous levodopa administration in parkinsonian patients.

Authors:  I Shoulson; G A Glaubiger; T N Chase
Journal:  Neurology       Date:  1975-12       Impact factor: 9.910

10.  Changes in plasma growth hormone levels in normal and acromegalic subjects following administration of 2-bromo-alpha-ergocryptine.

Authors:  F Camanni; F Massara; L Belforte; G M Molinatti
Journal:  J Clin Endocrinol Metab       Date:  1975-03       Impact factor: 5.958

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.